Suppression of long non‐coding RNA TNRC6C‐AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway

Mapping the STK4/Hippo signaling network in prostate cancer cell

(2017) Damien Ready et al.   PLoS One

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis

(2016) Sandya Liyanarachchi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro

(2016) Sandra M. Ayuk et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

Thyroid carcinoma in Graves’ disease: A meta-analysis

(2016) Joy U.L. Staniforth et al.   International Journal of Surgery

LC3 is a novel substrate for the mammalian Hippo kinases, STK3/STK4

(2015) Deepti S Wilkinson et al.   Autophagy

STK4 regulates TLR pathways and protects against chronic inflammation–related hepatocellular carcinoma

(2015) Weiyun Li et al.   JOURNAL OF CLINICAL INVESTIGATION

Phosphorylation of LC3 by the Hippo Kinases STK3/STK4 Is Essential for Autophagy

(2015) Deepti S. Wilkinson et al.   MOLECULAR CELL

Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR)

(2015) Qinyi Zhou et al.   TUMOR BIOLOGY

NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition

(2015) M. E. R. Garcia-Rendueles et al.   Cancer Discovery

Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4′-thio-2′-deoxycytidine and 5-aza-4′-thio-2′-deoxycytidine

(2014) Jaideep V. Thottassery et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Where long noncoding RNAs meet DNA methylation

(2014) Fan Lai et al.   CELL RESEARCH

The Hippo signaling pathway in stem cell biology and cancer

(2014) J.-S. Mo et al.   EMBO REPORTS

Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based treatment for non-small cell lung cancer

(2014) SHOUFENG WANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Noncoding RNAs in Endocrine Malignancy

(2014) J. Kentwell et al.   ONCOLOGIST

MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo

(2014) T-I Hsu et al.   Oncogenesis

Efficacy of lentiviral-mediated transfection of hTSHR in poorly differentiated thyroid carcinoma cell line

(2013) Weiwei Cheng et al.   NUCLEAR MEDICINE AND BIOLOGY

RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer

(2013) S E Lee et al.   Oncogenesis

Threonine-120 Phosphorylation Regulated by Phosphoinositide-3-Kinase/Akt and Mammalian Target of Rapamycin Pathway Signaling Limits the Antitumor Activity of Mammalian Sterile 20-Like Kinase 1

(2012) Filiz Kisaayak Collak et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients

(2011) HANNA PELTTARI et al.   APMIS

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

(2009) M. D. Robinson et al.   BIOINFORMATICS

Poorly Differentiated Thyroid Carcinoma: 5 Years after the 2004 WHO Classification of Endocrine Tumours

(2009) Marco Volante et al.   ENDOCRINE PATHOLOGY